Amlodipine accelerates bone healing in a stable closed femoral fracture model in mice
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Calcium channel blockers (CCBs), which are widely used in the treatment of hypertension, have been shown to influence bone metabolism. However, there is little information on whether CCBs also influence the process of fracture healing. Therefore, the effect of the CCB amlodipine on bone healing was studied in a stable closed fracture model in mice using intramedullary screw fixation. Bone healing was investigated by radiology, biomechanics, histomorphometry and Western blot analysis 2 and 5 weeks after fracture healing. Animals were treated daily (post operatively) per os using a gavage with amlodipine low dose (1 mg/ kg body weight, n = 20), amlodipine high dose (3 mg/kg body weight, n = 20) or vehicle (NaCl) (control, n = 20) serving as a negative control. At 2 and 5 weeks, histomorphometric analysis revealed a significantly larger amount of bone tissue within the callus of amlodipine low-dose- and high-dose-treated animals when compared to controls. This was associated with a smaller amount of cartilaginous and fibrous tissue, indicating an acceleration of fracture healing. Biomechanics showed a slightly, but not significantly, higher bending stiffness in amlodipine low-dose- and high-dose-treated animals. Western blot analysis revealed a significantly increased expression of bone morphogenetic protein (BMP)-2 and vascular endothelial growth factor (VEGF). Moreover, the analysis showed a 5-fold higher expression of osteoprotegerin (OPG) and a 10-fold elevated expression of the receptor activator of NF-κB ligand (RANKL), indicating an increased bone turnover. These findings demonstrated that amlodipine accelerated fracture healing by stimulating bone formation, callus remodelling and osteoclast activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In animal studies, amlodipine (114), cilostazol (115), L-arginin (116), sildenafil (117), and metformin (118) were shown to facilitate fracture healing.”
From Methods to accelerate fracture healing – a narrative review from a clinical perspective (2024) · cites this paper as [114]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439 · cited 1×
“On the other hand, OPG is a soluble decoy receptor for RANKL that interferes with RANKL-RANK binding, leading to an inhibition of osteoclastogenesis (Lacey et al., 1998; Simonet et al., 1997).”
BackgroundOsteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
OSTEOGENIC ACTIVITY OF THE FOURTEEN TYPES OF HUMAN BONE MORPHOGENETIC PROTEINS (BMPS)
CHENG, H., JIANG, W., PHILLIPS, F. M., HAYDON, R. C., PENG, Y., ZHOU, L., LUU, H. H., AN, N., BREYER, B., VANICHAKARN, P., et al. (2003) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200308000-00017 · Cited by 1,012
Osteoblast–osteoclast interactions
Chen, X., Wang, Z., Duan, N., Zhu, G., Schwarz, E. M., & Xie, C. (2018) · Connective Tissue Research · doi:10.1080/03008207.2017.1290085 · Cited by 873 · cited 1×
“Moreover, it is widely accepted that osteoblasts express RANKL and, thus, stimulate osteoclastogenesis themselves (Chen et al., 2018).”
BackgroundCarano, R. A. D., & Filvaroff, E. H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02866-6 · Cited by 746
Osteoclasts: What Do They Do and How Do They Do It?
Teitelbaum, S. L. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060834 · Cited by 730
Prevention of fracture healing in rats by an inhibitor of angiogenesis
Hausman, M. R., Schaffler, M. B., & Majeska, R. J. (2001) · Bone · doi:10.1016/s8756-3282(01)00608-1 · Cited by 384 · cited 1×
“The importance of a sufficient vascularisation is supported by experimental studies demonstrating that an inhibition of VEGF signalling leads to an impaired bone healing and non-union formation (Hausman et al., 2001).”
BackgroundSi, W., Kang, Q., Luu, H. H., Park, J. K., Luo, Q., Song, W.-X., Jiang, W., Luo, X., Li, X., Yin, H., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.2955-2964.2006 · Cited by 272 · cited 1×
“CYR61 plays an important role in the process of bone healing by the stimulation of osteoblast differentiation and proliferation (Si et al., 2006).”
BackgroundGerstenfeld, L. C., Sacks, D. J., Pelis, M., Mason, Z. D., Graves, D. T., Barrero, M., Ominsky, M. S., Kostenuik, P. J., Morgan, E. F., & Einhorn, T. A. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081113 · Cited by 218 · cited 1×
“Cartilage resorption during fracture healing is associated with a peak in RANKL and OPG expression (Gerstenfeld et al., 2009).”
Background
Research works printed but not linked: 1
- Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cifkova R, Dominiczak AF, Grassi G, Jordan J, Poulter NR, Rodgers A, Whelton PK (2018) Hypertension. Nat Rev Dis Primers 4: 18014. DOI: 10.1038/nrdp.2018. · doi:10.1038/nrdp.2018
Cited by
Advanced Progress of the Relationship Between Antihypertensive Drugs and Bone Metabolism
Zhang, R., Yin, H., Yang, M., Lei, X., Zhen, D., & Zhang, Z. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21648 · Cited by 43
Methods to accelerate fracture healing – a narrative review from a clinical perspective
Ganse, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1384783 · Cited by 33
Menger, M. M., Bauer, D., Bleimehl, M., Scheuer, C., Braun, B. J., Herath, S. C., Rollmann, M. F. R., Menger, M. D., Laschke, M. W., & Histing, T. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04441-8 · Cited by 12
“Successful bone regeneration requires osteoclastmediated cartilage and bone resorption within the callus tissue [50].”
BackgroundDevelopment of an ischemic fracture healing model in mice
Menger, M. M., Stutz, J., Ehnert, S., Nussler, A. K., Rollmann, M. F. R., Herath, S. C., Braun, B. J., Pohlemann, T., Menger, M. D., & Histing, T. (2022) · Acta Orthopaedica · doi:10.2340/17453674.2022.2529 · Cited by 11
“Of note, we observed a reliable femoral fracture consolidation at 5 weeks after surgery with the present model in previous studies (8,9).”
ResultMenger, M. M., Emmerich, M., Scheuer, C., Hans, S., Braun, B. J., Herath, S. C., Rollmann, M. F. R., Menger, M. D., Laschke, M. W., & Histing, T. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116291 · Cited by 7
Metadata
- Authors
- Department of Trauma and Reconstructive Surgery, E. K. U. T., Menger, M., Merscher, B., Scheuer, C., Braun, B., Herath, S., Rollmann, M., Stenger, D., Später, T., Pohlemann, T., Menger, M., & Histing, T.
- Affiliations
- Saarland University (DE)
- University of Tübingen (DE)
- Venue
- European Cells and Materials
- Publisher
- Forum Multimedia Publishing LLC
- Published
- 2021-05-24
- Volume
- 41
- Pages
- 592-602
- ISSN
- 1473-2262 (ISSN-L)
- OpenAlex
- W3164549844
- Cited by
- 16
- References
- 47
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 6 · 2023: 2 · 2022: 1
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- European Cells and Materials (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Servier
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone fractures and treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- amlodipine, calcium channel blockers, fracture healing, femoral fracture, intramedullary screw fixation, BMP-2, vascular endothelial growth factor, osteoprotegerin, RANKL, bone turnover, osteoclast activity, bone formation
- MeSH terms
- Animals, Bone Screws, Calcium Channel Blockers, Bony Callus, Disease Models, Animal, Femoral Fractures, Femur, Osteoclasts, Osteogenesis, Bone Remodeling, Fracture Healing, Amlodipine, Vascular Endothelial Growth Factor A, Mice, RANK Ligand, Bone Morphogenetic Protein 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amlodipine accelerates bone healing in a stable closed femoral fracture model in mice. https://app.cochat.ai/papers/10.22203/ecm.v041a38
- The paper
- Department of Trauma and Reconstructive Surgery, E. K. U. T., Menger, M., Merscher, B., Scheuer, C., Braun, B., Herath, S., Rollmann, M., Stenger, D., Später, T., Pohlemann, T., Menger, M., & Histing, T. (2021). Amlodipine accelerates bone healing in a stable closed femoral fracture model in mice. European Cells and Materials. https://doi.org/10.22203/ecm.v041a38
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.








